Punteggio | 29 |
|---|---|
Vol. in 24 ore | 388,64 $ |
Liquidità | 2K $ |
Titolari | 111 |
Audit | |
Età | 2 giorni |
FDV | 1,9K $ |
Market cap | 1,9K $ |
Moderna Inc (mRNA)
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
Aggiorna le informazioni sul tokenmRNA/SOL Statistiche prezzi
Il prezzo attuale di mRNA (mRNA/SOL) su PumpSwap è 0,000001933 $, il prezzo è cresciuto di -26,57% nelle ultime 24 ore. Il suo volume di trading in 24 ore si attesta a 388,64 $ per un totale di 25 transazioni. L'indirizzo di contatto di mRNA/SOL è 8PuiDczBmQuTHtwK4YjtRsViQ74hE2jKZY4ib7wrfxN2, con una valutazione totalmente diluita (FDV) di 1.932,60 $ e un pool di liquidità di 1.952,57 $.
